Factoring in frailty when optimising medication

Abstract

The relationship between polypharmacy and frailty was the subject of the 2018 Annual Scientific Meeting of PRIMM (Prescribing and Research in Medicines Management), held in London in January. Professor Janet Krska reports on some of the advice given at the meeting, including identifying frailty and adopting a patient‐centred approach to medicines optimisation.